Clik here to view.
Pharmalot.. Pharmalittle.. We’re catching up on antipsychotics, Califf and…
thoseguys119 on flickr creative commons Hello, everyone, and how are you today? A bright, shiny sun is enveloping the Pharmalot campus, where the shortest of short people has left for the local...
View ArticleClik here to view.
The problem with using surrogate markers to approve cancer drugs
thx to allan ferguson on flickr creative commons In 2003, the Food and Drug Administration approved a lung cancer drug called Iressa, but not because the medicine helped patients live longer. Instead,...
View ArticleClik here to view.
What warning letter? Amid free speech battle, FDA yanks Pacira letter
thx to sammynetbook on flickr creative commons It’s not every day that the Food and Drug Administration removes a warning letter from its web site. But the agency did just that recently when it pulled...
View ArticleClik here to view.
Do prescription drug prices worry you? Join our Twitter chat and discuss
Peter Bach of Memorial Sloan Kettering Cancer Center Some drug makers are buying medicines from other companies and jacking up prices by 200, 500 and even 5,000 percent. New cancer treatments are so...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. We’re catching up on Pharma lobbying, Biogen and…
coffee thx to chichacha on flickr creative commons Good morning, everyone, and how are you today? We are just fine, thank you. In fact, we are thrilled to report that we have made it to the middle of...
View ArticleClik here to view.
Valeant denies short seller report that bludgeoned its stock
thx to chris potter on flickr creative commons The Valeant Pharmaceuticals story is going from bad to worse. The latest installment involves accusations by an influential short seller that the drug...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. We’re catching up on Gilead, Theranos and…
sunrise thx to noel pennington on flickr creative commons Top of the morning to you. And another fine one, it is. The sun is shining, the Pharmalot campus is blissfully quiet and more cups of...
View ArticleClik here to view.
How to decide if a cancer drug is worth the cost NCCN’s Carlson explains
Robert Carlson, NCCN The clamor over prescription drug pricing often implies that medicines simply cost too much. But many experts say the debate can easily overlook an important point – is a given...
View ArticleClik here to view.
Martin Shkreli may get competition for his pricey drug, after all
thx to william warby on flickr creative commons Thanks to a compounding pharmacy, Martin Shkreli’s company may no longer have a lock on the market for its pricey anti-infective drug Daraprim. A...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. As the weekend nears.. we’re catching up on...
pic thx to jake cook on flickr creative commons And so, another working week is about to draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Valeant, Glaxo...
coffee thx to chichacha on flickr creative commons Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that all-too-familiar...
View ArticleClik here to view.
Prescription drug price hikes are slowing this year… so far, anyway
pic thx to pictures of money flickr creative commons The price tags for prescription drugs are a red-hot issue that is increasingly causing concern among consumers, physicians and insurers. Even some...
View ArticleClik here to view.
Amgen reviews privacy of patient assistance program for cholesterol drug
pic thx to owen moore on flickr creative commons In response to criticism, Amgen is reviewing privacy provisions in a patient assistance program for its pricey new cholesterol medicine which is called...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Sanofi, Glaxo...
pic thx to william yurasko on flickr creative commons Good morning, everyone, and how are you today? We are just fine, thank you, and busy as ever. We are, in fact, on the road as we plan to huddle...
View ArticleClik here to view.
Novartis to pay $390M to settle kickback case, but will execs pay a price?
thx to pictures of money on flickr creative commons On the eve of a closely watched trial that was to have begun next week, Novartis has agreed to pay $390 million to settle charges of paying kickbacks...
View ArticleClik here to view.
The eyes have it: FTC probes Valeant over contact lens
pic thx to niek beck on flickr creative commons The Federal Trade Commission is investigating whether Valeant Pharmaceuticals illegally cornered the market for a key component of rigid contact lenses,...
View ArticleClik here to view.
Budget requires generic makers to pay Medicaid rebates tied to inflation
pic thx to images money on flickr creative commons For those concerned about the rising cost of pharmaceuticals, Congress is proposing some relief. The two-year budget deal proposed by lawmakers this...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Theranos,...
pic thx to soe lin on flickr creative commons Top of the morning to you. And a fine one, it is. Although a bit cloudy here in New England, our spirits remain sunny. As you know, our philosophy,...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. Good Morning.. We’re catching upon Valeant,...
pic thx to mick kelly on flickr creative commons Good morning, folks. A happy, shiny sun is hovering over the Pharmalot campus where, after a brief road trip, we have resumed our usual ritual of...
View ArticleClik here to view.
Doctor indicted for taking kickbacks and giving drug maker patient data
thx to pictures of money on flickr creative commons In an unusual move, federal authorities indicted a physician for releasing patient data and accepting $23,500 in exchange for writing prescriptions...
View Article
